相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation
D Hind et al.
HEALTH TECHNOLOGY ASSESSMENT (2014)
Health-related quality of life in patients with metastatic colorectal cancer treated with panitumumab in first- or second-line treatment
L. Bennett et al.
BRITISH JOURNAL OF CANCER (2011)
Health-related quality of life and colorectal cancer-specific symptoms in patients with chemotherapy-refractory metastatic disease treated with panitumumab
Dawn Odom et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2011)
Toward optimized front-line therapeutic strategies in patients with metastatic colorectal cancer-an expert review from the International Congress on Anti-Cancer Treatment (ICACT) 2009
R. Adam et al.
ANNALS OF ONCOLOGY (2010)
Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment
E. Van Cutsem et al.
ANNALS OF ONCOLOGY (2010)
Metastatic Colorectal Cancer: From Improved Survival to Potential Cure
David J. Gallagher et al.
ONCOLOGY (2010)
Preference values associated with stage III colon cancer and adjuvant chemotherapy
Jennie H. Best et al.
QUALITY OF LIFE RESEARCH (2010)
Cost-effectiveness analysis of XELOX for metastatic colorectal cancer based on the NO16966 and NO16967 trials
T. Shiroiwa et al.
BRITISH JOURNAL OF CANCER (2009)
Bevacizumab Beyond First Progression Is Associated With Prolonged Overall Survival in Metastatic Colorectal Cancer: Results From a Large Observational Cohort Study (BRiTE)
Axel Grothey et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Cost-effectiveness analysis of cetuximab/irinotecan vs active/best supportive care for the treatment of metastatic colorectal cancer patients who have failed previous chemotherapy treatment
N. Starling et al.
BRITISH JOURNAL OF CANCER (2007)
分享论文
